US warns against use of fluoroquinolones for uncomplicated infections

BMJ 2016; 353 doi: (Published 16 May 2016) Cite this as: BMJ 2016;353:i2755
  1. Michael McCarthy
  1. Seattle

The risk of the serious side effects associated with fluoroquinolone antibiotics outweighs their benefits for the treatment of sinusitis, bronchitis, and uncomplicated urinary tract infections, the US Food and Drug Administration (FDA) said in an advisory issued …

View Full Text

Log in

Log in through your institution


* For online subscription